Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2023-04-17 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-04-17 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed notice regarding a rights offering (placement de droits) by Algernon Pharmaceuticals Inc. It includes information about the terms of the rights offering, subscription prices, expiration dates, eligibility, and regulatory disclaimers. The text is not a financial report, earnings release, or management discussion. It is a formal offering document aimed at shareholders to inform them about the rights issue and how to participate. This fits the category of Capital/Financing Update (CAP), as it relates to company fundraising activities and capital structure changes. The document length (15,000 characters) and detailed content confirm it is the actual notice, not just an announcement of a report. Therefore, the correct classification is CAP with high confidence.
2023-03-22 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO of Cresco Labs Inc. It certifies the review and fair presentation of the annual filings for the financial year ended December 31, 2022. The document is a certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certificate and includes disclaimers about the scope of the certification. The document length is 3101 characters, which is relatively short and consistent with a certification letter rather than a full annual report. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the report they reference (e.g., Annual Report 10-K). Therefore, the correct classification is Regulatory Filings (RNS).
2023-03-22 English
Annual information form - English.pdf
Annual Report Classification · 95% confidence The document is titled 'Annual Information Form' for the year ended December 31, 2022, dated March 21, 2023. It contains detailed sections such as corporate structure, risk factors, dividends, capital structure, directors and executive officers, legal proceedings, and auditor information. It references audited consolidated financial statements and management's discussion and analysis (MD&A) for the fiscal year ended December 31, 2022. The document is comprehensive and contains substantive financial and business information for the full fiscal year. This matches the characteristics of an Annual Report (10-K equivalent) rather than a brief announcement or a regulatory filing. Therefore, the appropriate classification is Annual Report (10-K). FY 2022
2023-03-22 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Years Ended December 31, 2022 and 2021,' which is a classic indicator of an MD&A section. It discusses detailed financial condition, results of operations, company overview, recent developments, and financial components such as revenue and gross profit. The document contains substantive financial data and analysis for a full fiscal year period, not just a brief announcement or summary. It is supplemental to the audited consolidated financial statements and annual information form, indicating it is part of the comprehensive management report explaining financial results and business trends. Therefore, this document fits the category of Management Reports (MDA).
2023-03-22 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-501F1' and is a Management Certification related to participation fees for reporting issuers, submitted to the Alberta Securities Commission. It contains certification by an officer (Chief Financial Officer) confirming the accuracy of the information provided. The content includes market value calculations for securities and fee computations but does not contain financial statements or substantive financial data typical of annual or interim reports. The document is primarily a certification and fee calculation form submitted to a regulatory body, fitting the criteria for a Regulatory Filing (RNS) rather than a full financial report or other specific filing types.
2023-03-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.